tirzepatide vs semaglutide weight loss comparison caused roughly half as many patients to stop treatment because of gastrointestinal side effects as semaglutide. In the first major head-to-head obesity trial, GI side effects caused treatment discontinuation in: Tirzepatide Semaglutide vs Tirzepatide: Weight Loss,

Experts address medical causation, epidemiology, and proper labeling practices, factoring in the reported side effects of drugs like Ozempic, including vision loss, gastrointestinal issues, and severe gastroparesis

doi: 10.1038/nature18646 106 De AngelisMPiccoloMVanniniLSiragusaSDe GiacomoASerrazzanettiDIet al

How Genetic Predispositions May Inform Your GLP-1 Readiness Emerging evidence suggests that variants in GLP-1 receptor pathways, GIPR signaling, and metabolic regulatory genes may influence individual response patterns to GLP-1 therapy

A 2011 study published in the European Review for Medical and Pharmacological Sciences has found that using digestive enzymes may reduce symptoms of IBS, including abdominal pain, diarrhea, gas, and bloating ( 11 )